WHO ICTRP trial
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled…
EUCTR2004-000142-20-CZ · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2004-000142-20-CZ |
|---|---|
| Public title | A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention - APEX-AMI |
| Scientific title | A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention - APEX-AMI |
| Primary sponsor | Procter & Gamble Pharmaceuticals |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Czech Republic;Spain;Italy;Sweden |
| Conditions | Following as ST-wave elevation myocardial infarction, there is local ischemia. When reperfusion occurs, there is a complement mediated inflammatory reponse, known as reperfusion injury, and a systemic inflammatory response. The outcome of… |
| Interventions | Product Name: pexelizumab Product Code: h5G1.1-scFv Pharmaceutical Form: Solution for injection Pharmaceutical form of the placebo: Solution for injection Route of administration of the placebo: Intravenous bolus use (Noncurrent) |
| Registration date | Mar 11, 2004 |
| Target size | 8500 |
| Secondary IDs | 2003056 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: